Literature DB >> 2225352

Interrelation between pinacidil and intracellular ATP concentrations on activation of the ATP-sensitive K+ current in guinea pig ventricular myocytes.

K Nakayama1, Z Fan, F Marumo, M Hiraoka.   

Abstract

The patch-clamp technique was used to study the relation between pinacidil and intracellular ATP concentration [( ATP]i) on the activation of the outward K+ current in guinea pig ventricular myocytes. Pinacidil shortened the action potential duration, exhibiting stronger effect at 2 mM [ATP]i than at 5 mM [ATP]i. Pinacidil at 5 microM or higher concentrations activated the time-independent outward current at potentials positive to -80 mV, and the pinacidil-activated current was suppressed by increasing [ATP]i from 2 to 5 mM. The dose-response curve of pinacidil at different [ATP]i showed a shift to the right and a depression of the maximum response at increased [ATP]i. The pinacidil-induced shortening of the action potential duration and outward current were inhibited by application of 0.3-1.0 microM glibenclamide. In single-channel current recordings, pinacidil activated the intracellular ATP-sensitive K+ channel current without changing the unitary amplitude, and increased open probability of the channel, an effect dependent on [ATP]i. The pinacidil-activated single-channel current was blocked by glibenclamide. These results prove the notion that pinacidil activates the ATP-sensitive K+ channel current, which explains the action potential shortening in cardiac cells after application of pinacidil.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2225352     DOI: 10.1161/01.res.67.5.1124

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  13 in total

Review 1.  ATP-sensitive potassium channels and myocardial ischemia: why do they open?

Authors:  W A Coetzee
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

Review 2.  Electrophysiologic effects of potassium channel openers.

Authors:  W Haverkamp; M Borggrefe; G Breithardt
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

Review 3.  K channel openers activate different K channels in vascular smooth muscle cells.

Authors:  K Kitamura; M Kamouchi
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

4.  Activation and reactivation of the ATP-sensitive K+ channel of the heart can be modified by drugs.

Authors:  M Hiraoka; Z Fan; T Furukawa; K Nakayama; T Sawanobori
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

5.  SR47063, a potent channel opener, activates KATP and a time-dependent current likely due to potassium accumulation.

Authors:  Y Tourneur; A Marion; P Gautier
Journal:  J Membr Biol       Date:  1994-12       Impact factor: 1.843

6.  Levcromakalim may induce a voltage-independent K-current in rat portal veins by modifying the gating properties of the delayed rectifier.

Authors:  G Edwards; T Ibbotson; A H Weston
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

7.  Contribution of potassium accumulation in narrow extracellular spaces to the genesis of nicorandil-induced large inward tail current in guinea-pig ventricular cells.

Authors:  K Yasui; T Anno; K Kamiya; M R Boyett; I Kodama; J Toyama
Journal:  Pflugers Arch       Date:  1993-01       Impact factor: 3.657

8.  ATP-sensitive K+ channels in cardiac ischemia: an endogenous mechanism for protection of the heart.

Authors:  W C Cole
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

9.  Aromatic aldehydes and aromatic ketones open ATP-sensitive K+ channels in guinea-pig ventricular myocytes.

Authors:  Z Fan; K Nakayama; T Sawanobori; M Hiraoka
Journal:  Pflugers Arch       Date:  1992-08       Impact factor: 3.657

10.  NADH supplementation decreases pinacidil-primed I K ATP in ventricular cardiomyocytes by increasing intracellular ATP.

Authors:  Brigitte Pelzmann; Seth Hallström; Peter Schaffer; Petra Lang; Karl Nadlinger; George D Birkmayer; Karoline Vrecko; Gilbert Reibnegger; Bernd Koidl
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.